| abstract |
The present invention has the potential to be used as a drug substance in pharmaceuticals (1R,3R,15E,28R,29R,30R,31R,34R,36R,39S,41R)-29,41-difluoro-34,39-bis( Sulfanyl)-2,33,35,38,40,42-hexaoxa-4,6,9,11,13,18,20,22,25,27-decaza-34λ 5 ,39λ 5 -diphospha octa-bicyclo [28.6.4.1 3,36 .1 28,31 .0 4,8 .0 7,12 .0 19,24 .0 23,27] FIG tetrahydro konta -5,7,9,11,15,19 ,21,23,25-Nonaene-34,39-dione (Compound I) ammonium salt, Compound I sodium salt or Compound I crystals are provided: . |